BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
24h
Atual
Mín
119.7
Máximo
122.55
Rendimento | -142M 667M |
---|---|
Vendas | 152M 5.4B |
P/E Médio do Setor | 26.27 57.333 |
EPS | 2.2 |
Rendimento de Dividendos | 1.34 |
Margem de lucro | 12.311 |
EBITDA | 85M 1.6B |
Recomendações | Comprar |
---|---|
Previsão para 12 meses | +38.83% upside |
Rendimento de Dividendos Médio do Setor | 1.34% 2.63% |
---|---|
Próximos Ganhos | 15 de mai. de 2025 |
Capitalização de Mercado | 33B 98B |
---|---|
Abertura anterior | 119.98 |
Fecho anterior | 121.4 |
By Trading Central
Confiança
Very Strong Bullish Evidence
117.55 / 120.4 Suporte e Resistência
O desempenho passado não é um indicador confiável de resultados futuros.
6 de mar. de 2025, 06:27 UTC
Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results
DJ
Ler
11 de fev. de 2025, 07:03 UTC
Germany's Merck in Talks to Buy SpringWorks Therapeutics
DJ
Ler
10 de fev. de 2025, 16:38 UTC
SpringWorks Therapeutics Shares Rise on Report it May be Acquired
DJ
Ler
24 de abr. de 2025, 22:51 UTC
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update
DJ
Ler
24 de abr. de 2025, 20:54 UTC
Merck KGaA: No Final Decision Has Been Taken; No Legally Binding Agreement Has Been Entered Into
DJ
Ler
24 de abr. de 2025, 20:50 UTC
Merck KGaA Confirms Late-Stage Discussions With SpringWorks Therapeutics on Potential Acquisition for About 47c a Share
DJ
Ler
24 de abr. de 2025, 19:05 UTC
Merck KGaA Expected to Pay Close to $47 a Share for SpringWorks, Sources Say -- WSJ
DJ
Ler
24 de abr. de 2025, 19:05 UTC
Merck KGaA, SpringWorks Deal Expected to Be Finalized as Soon as Monday, Sources Say -- WSJ
DJ
Ler
24 de abr. de 2025, 19:05 UTC
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- WSJ
DJ
Ler
24 de abr. de 2025, 19:05 UTC
Merck KGaA Nears Roughly $3.5 Billion Takeover of SpringWorks Therapeutics, Sources Say -- WSJ
DJ
Ler
6 de mar. de 2025, 11:18 UTC
Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk
DJ
Ler
6 de mar. de 2025, 11:14 UTC
Merck KGaA's Outlook Signals Greater Transparency -- Market Talk
DJ
Ler
6 de mar. de 2025, 08:20 UTC
Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk
DJ
Ler
6 de mar. de 2025, 06:00 UTC
Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B
DJ
Ler
6 de mar. de 2025, 06:00 UTC
Merck KGaA 2024 Adj EPS EUR8.63
DJ
Ler
6 de mar. de 2025, 06:00 UTC
Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B
DJ
Ler
6 de mar. de 2025, 06:00 UTC
Merck KGaA 2024 EBIT EUR3.645B
DJ
Ler
6 de mar. de 2025, 06:00 UTC
Merck KGaA 2024 After-Tax Profit EUR2.79B
DJ
Ler
6 de mar. de 2025, 06:00 UTC
Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B
DJ
Ler
6 de mar. de 2025, 06:00 UTC
Merck KGaA 2024 EBITDA EUR5.78B
DJ
Ler
6 de mar. de 2025, 06:00 UTC
Merck KGaA 2024 Sales EUR21.16B
DJ
Ler
6 de mar. de 2025, 06:00 UTC
Merck KGaA Keeps Dividend at EUR2.20
DJ
Ler
6 de mar. de 2025, 06:00 UTC
Analysts Saw Merck KGaA 2024 Sales at EUR21.14B
DJ
Ler
6 de mar. de 2025, 06:00 UTC
Analysts Saw Merck KGaA 2024 Ebitda Before One-Time Items at EUR6.08B
DJ
Ler
11 de fev. de 2025, 16:45 UTC
Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk
DJ
Ler
11 de fev. de 2025, 10:54 UTC
Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk
DJ
Ler
11 de fev. de 2025, 10:52 UTC
German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk
DJ
Ler
6 de jan. de 2025, 13:08 UTC
Merck KGaA: Transaction closed on Dec. 23, 2024
DJ
Ler
6 de jan. de 2025, 13:07 UTC
Merck KGaA: Didn't Disclose Financial Details
DJ
Ler
6 de jan. de 2025, 13:06 UTC
Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio
DJ
Ler
Variação de preço
By TipRanks
Previsão para 12 meses
Média 166.25 EUR 38.83%
Máximo 190 EUR
Mínimo 107 EUR
Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para Merck KGaA - Dist nos últimos 3 meses.
By TipRanks
Comprar
9 ratings
6
Comprar
2
Manter
1
Vender
Com base em 9 analistas que deram avaliações de ações para Merck KGaA - Dist nos últimos 3 meses.
By Trading Central
Curto Prazo
Very Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Médio Prazo
Bearish Evidence
All events are bearish.
Longo Prazo
Bearish Evidence
All events are bearish.
Custos administrativos e de venda
Custos Operacionais
Lucro antes de imposto
Vendas
Custo das vendas
Lucro bruto sobre vendas
Despesa com juros da dívida
EBITDA
Resultado Operacional
$